SCHEMBL7425752

SCHEMBL7425752

CCOC(=O)CC(=O)CCc1n[nH]c2cc(C(=O)OC)cc(C)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.36
▸ PDE3B Q13370 2/20 0.36
▸ PDE3A Q14432 2/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ PDE1A P54750 1/20 0.36
▸ PDE1B Q01064 1/20 0.36
▸ PDE1C Q14123 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ PARP1 P09874 2/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HDAC5 Q9UQL6 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423380 0.84 ALDH1A1 (0.39) KDM4EALDH1A1PARP1NPC1LMNA
SCHEMBL7421945 0.78 PARP1 (0.36) KDM4EPDE3BPDE3AADORA1PDE1A
SCHEMBL7428711 0.71 BACE1 (0.43) KDM4EALDH1A1PARP1MEN1KMT2A
SCHEMBL7655673 0.67 LMNA (0.47) KDM4EALDH1A1NPC1MEN1KMT2A
SCHEMBL8319516 0.64 GAA (0.41) KDM4EPDE3BPDE3AALDH1A1MEN1
SCHEMBL7159712 0.62 CYP4F2 (0.64) KMT2ATDP1
SCHEMBL3603266 0.62 MAP2K4 (0.52) KDM4EALDH1A1PARP1NPC1MEN1
SCHEMBL12290429 0.62 CYP4F2 (0.58) ALDH1A1TDP1
SCHEMBL16175866 0.61 KDM4E (0.68) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL16850624 0.61 KDM4E (0.68) KDM4EALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054871-A2 PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-29 — — EP disclosed
WO-1999050249-A2 PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-07 — — WO disclosed
Send feedback